Therapeutic Strategy Details
| Strategy ID: | S18 |
| Strategy: | regulating intestinal flora |
| Other Terms: | Anti-inflammatory; Improve insulin resistance; Enhance lipid metabolism; Regulating intestinal flora; Anti-hypertensive; Improve insulin resistance; Enhance lipid metabolism; Regulating intestinal flora; Anti-fibrosis; gut microbiota modulation; innovative absorption-based approach; gut microbiota reprogramming; Regulating intestinal flora; Improve insulin resistance; Enhance lipid metabolism; Anti-inflammatory; Regulating intestinal flora; Modulation of IS production in the gut microbiota |
| Related Targets: | Smad2/3; Smad4 |
| Related Drugs: | berberine; Rehmannia glutinosa leaves total glycoside; synbiotic; broad-spectrum oral antibiotics; sodium acetate; GPR43 siRNA; inulin; choline analogues; histidine-based scaffold; isoquercitrin |
| Mechanism: | |
| Reference (PMIDs): | 32005442; 32028239; 32164382; 32194836; 32526852; 32827245; 33016221 |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|
| Candidate ID | Source ID | Source Type | Compound Type | Candidate Name | Inclusion Criteria |
|---|
| Article ID | PMID | Source | Title |
|---|